Objective: for patients with acute cerebral infarction, choosing intravenous thrombolytic therapy and pulmonary vein distress therapy in the process of disease treatment operation, to discuss the impact on the treatme...Objective: for patients with acute cerebral infarction, choosing intravenous thrombolytic therapy and pulmonary vein distress therapy in the process of disease treatment operation, to discuss the impact on the treatment effect, and to analyze the relevant nursing experience. Methods: from January 2021 to January 2022, patients who entered our hospital for hyperacute cerebral infarction treatment were taken as research samples, and the basic recovery status, bleeding probability, nursing efficiency and other indicators of the two groups of patients were evaluated. Compare and analyze. Results: from the analysis of the clinical treatment effect of the two groups of patients, it can be known that the clinical treatment effect of the routine group patients was 15.2%, and the clinical treatment effect of the study group patients was 42.4%. From the analysis of the incidence of bleeding in the two groups of patients, it can be known that the incidence of bleeding in the conventional group is 9.1%, and the incidence of bleeding in the research group is 15.2%. Conclusion: intravenous thrombolytic therapy is an effective treatment measure for hyperacute cerebral infarction. It can improve the patient's disease, and the treatment effect can also control the recurrence rate, and the patient's quality of life can be optimized under the condition of reducing bleeding changes and improve.展开更多
文摘Objective: for patients with acute cerebral infarction, choosing intravenous thrombolytic therapy and pulmonary vein distress therapy in the process of disease treatment operation, to discuss the impact on the treatment effect, and to analyze the relevant nursing experience. Methods: from January 2021 to January 2022, patients who entered our hospital for hyperacute cerebral infarction treatment were taken as research samples, and the basic recovery status, bleeding probability, nursing efficiency and other indicators of the two groups of patients were evaluated. Compare and analyze. Results: from the analysis of the clinical treatment effect of the two groups of patients, it can be known that the clinical treatment effect of the routine group patients was 15.2%, and the clinical treatment effect of the study group patients was 42.4%. From the analysis of the incidence of bleeding in the two groups of patients, it can be known that the incidence of bleeding in the conventional group is 9.1%, and the incidence of bleeding in the research group is 15.2%. Conclusion: intravenous thrombolytic therapy is an effective treatment measure for hyperacute cerebral infarction. It can improve the patient's disease, and the treatment effect can also control the recurrence rate, and the patient's quality of life can be optimized under the condition of reducing bleeding changes and improve.
